EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/25/2018
Outstanding shares:  28,398,789
Average volume:  396,357
Market cap:   $106,211,471
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30234E104
ISIN:        US30234E1047
Valuation   (See tab for details)
PE ratio:   -7.38
PB ratio:   22.80
PS ratio:   17.70
Return on equity:   -470.28%
Net income %:   -332.81%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy